Top Growth Stocks With Strong Insider Ownership For August 2026
RUM Group RUM | 0.00 |
The United States market has experienced a positive trajectory, up 1.2% over the last week and 18% over the past 12 months, with earnings forecasted to grow by 17% annually. In such an environment, growth companies with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the business in its future potential.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Uxin (UXIN) | 34.3% | 69.4% |
| Upstart Holdings (UPST) | 13.9% | 65.6% |
| Precigen (PGEN) | 11.7% | 55.4% |
| Nu Holdings (NU) | 22.8% | 20% |
| Karman Holdings (KRMN) | 14.5% | 54% |
| Himax Technologies (HIMX) | 29.2% | 70.2% |
| Dave (DAVE) | 17% | 23.2% |
| Carlyle Group (CG) | 27.5% | 20.5% |
| Astera Labs (ALAB) | 10% | 33.2% |
| Almonty Industries (ALM) | 10.8% | 38% |
Here's a peek at a few of the choices from the screener.
RUM Group (RUM)
Simply Wall St Growth Rating: ★★★★★☆
Overview: RUM Group Inc. operates a video sharing and cloud services platform across the United States, Canada, and internationally with a market cap of $3.75 billion.
Operations: The company generates revenue of $117.66 million from its Internet Software & Services segment.
Insider Ownership: 30.5%
Return On Equity Forecast: N/A (2029 estimate)
RUM Group, recently renamed from Rumble Inc., is poised for significant growth with forecasted revenue increases of 81.3% annually, outpacing the US market. Despite past shareholder dilution and recent board changes, including Paul Cappuccio's resignation, the company maintains a strong growth trajectory. Recent earnings showed increased sales but also higher net losses. Partnerships like the one with Together AI highlight RUM's strategic positioning in AI infrastructure outside traditional ecosystems, supporting its long-term expansion goals.
Atlassian (TEAM)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Atlassian Corporation offers collaboration software designed to enhance organizational productivity globally, with a market cap of approximately $42.65 billion.
Operations: The company generates revenue primarily from its Software & Programming segment, which amounted to $6.57 billion.
Insider Ownership: 37.3%
Return On Equity Forecast: 35% (2029 estimate)
Atlassian Corporation is positioned for growth with forecasted earnings expansion of 42.58% annually, although its revenue growth at 12.2% per year lags behind the broader US market. Recent buybacks totaling $631.45 million reflect strategic capital allocation amid high insider ownership, despite recent insider selling activity. The introduction of Code Context enhances Atlassian's AI-native software development capabilities, potentially boosting productivity and integration across workflows, while a new Chief Product Officer aims to strengthen enterprise solutions and governance strategies.
Klaviyo (KVYO)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Klaviyo, Inc. offers a cloud-based software-as-a-service platform globally, with a market cap of approximately $5.07 billion.
Operations: The company's revenue is primarily derived from its internet software segment, totaling $1.39 billion.
Insider Ownership: 38.4%
Return On Equity Forecast: 25% (2029 estimate)
Klaviyo exhibits strong growth potential with earnings forecasted to expand significantly at 82.3% annually, outpacing the US market. Despite a slower revenue growth rate of 16.2%, the company trades at a substantial discount to its estimated fair value and maintains high insider ownership. Recent strategic moves include acquiring Agency to enhance AI capabilities and raising fiscal year revenue guidance, supported by robust cash flow and ongoing share repurchases totaling US$317.83 million.
Where To Now?
- Click this link to deep-dive into the 186 companies within our Fast Growing US Companies With High Insider Ownership screener.
- Want To Explore Some Alternatives? AI is about to change healthcare. These 133 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
